An estimated 10% to 20% of patients experience the onset of systemic lupus erythematosus
(SLE) before adulthood. More precise estimates are difficult due to a lack of a clear age limit …

… by serum osteo calcin (Spearman rank correlation coefficient r = –0.34, P <0.0001) [35]. …
doi:10.1186/ar4256 Cite this article as: Mina R, Brunner HI: Update on differences between …

T-cell redirecting bispecific antibodies (BsAbs) and chimeric antigen receptor T cells (CAR T
cells) have revolutionised multiple myeloma therapy, but adverse events such as cytokine …

Background Daratumumab, a monoclonal antibody targeting CD38, has been approved for
use with standard myeloma regimens. An evaluation of subcutaneous daratumumab …

Thalidomide and bortezomib are extensively used to treat elderly myeloma patients. In these
patients, treatment-related side effects are frequent and full drug doses difficult to tolerate. …

Purpose: Bortezomib-melphalan-prednisone (VMP) has improved overall survival in
multiple myeloma. This randomized trial compared VMP plus thalidomide (VMPT) induction …

Inspired by Lottery Ticket Hypothesis that competitive subnetworks exist within a dense
network, we propose a continual learning method referred to as Winning SubNetworks (WSN), …

… Mina and von Scheven contributed equally to this work. … Nezhad ST, Sepaskhah R.
Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year …

… (r ≥ |0.2|). In addition, some strong correlations between TF levels and levels of other
biomarkers were observed (r = 0.74, P < 0.0001 for the correlation between TF and CP levels; r = …

Malignant mesothelioma (MM) of the pleura or peritoneum is a universally fatal disease
attracting an increasing range of medical interventions and escalating healthcare costs. …